Lirilumab

http://dbpedia.org/resource/Lirilumab an entity of type: Thing

ليريلوماب جسم مضاد وحيد النسيلة بشري طورته بريستول مايرز سكويب لعلاج السرطان. rdf:langString

Lirilumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It binds to KIR2DL1/2L3. This drug was developed by Innate Pharma and is licensed to Bristol-Myers Squibb. rdf:langString

rdfs:label

rdf:langString ليريلوماب

rdf:langString Lirilumab

dbpedia-owl:wikiPageID

xsd:integer 38166296

dbpedia-owl:wikiPageRevisionID

xsd:integer 1092789530

dbpprop:atcPrefix

rdf:langString none

dbpprop:c

xsd:integer 6452

dbpprop:casNumber

xsd:integer 1000676

dbpprop:chemspiderid

rdf:langString none

dbpprop:h

xsd:integer 9918

dbpprop:kegg

rdf:langString D10444

dbpprop:n

xsd:integer 1698

dbpprop:o

xsd:integer 2030

dbpprop:s

xsd:integer 46

dbpprop:source

rdf:langString u

dbpprop:type

rdf:langString mab

dbpprop:unii

rdf:langString S9XDI9W918

dbpedia-owl:abstract

rdf:langString ليريلوماب جسم مضاد وحيد النسيلة بشري طورته بريستول مايرز سكويب لعلاج السرطان.

rdf:langString Lirilumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It binds to KIR2DL1/2L3. This drug was developed by Innate Pharma and is licensed to Bristol-Myers Squibb.

dbpprop:mabType

rdf:langString mab

dbpedia-owl:wikiPageLength

xsd:nonNegativeInteger 3544

dbpedia-owl:casNumber

xsd:string 1000676-41-4

dbpedia-owl:fdaUniiCode

xsd:string S9XDI9W918

dbpedia-owl:kegg

xsd:string D10444

rdf:type

owl:Thing